Stock Scorecard

Stock Summary for Novo Nordisk (NVO) - $44.39 as of 5/22/2026 3:05:06 PM EST

Total Score

13 out of 30

Safety Score

44 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for NVO

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for NVO

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for NVO

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for NVO

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for NVO (44 out of 100)

Stock Price Rating (Max of 10) 8
Historical Stock Price Rating (Max of 10) 9
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 4
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 6
Operating Margin (Max of 10) 8
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Financial Details for NVO

Company Overview
Ticker NVO
Company Name Novo Nordisk
Country N/A
Description Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark.
Sector Name HEALTHCARE
Industry Name DRUG MANUFACTURERS - GENERAL
Most Recent Quarter 3/31/2026
Next Earnings Date 8/5/2026

Stock Price History
Last Day Price 44.39
Price 4 Years Ago 62.22
Last Day Price Updated 5/22/2026 3:05:06 PM EST
Last Day Volume 11,627,958
Average Daily Volume 16,834,674
52-Week High 77.68
52-Week Low 34.58
Last Price to 52 Week Low 28.37%

Valuation Measures
Trailing PE N/A
Industry PE 22.38
Sector PE 73.16
5-Year Average PE 16.92
Free Cash Flow Ratio 7.06
Industry Free Cash Flow Ratio 40.48
Sector Free Cash Flow Ratio 29.12
Current Ratio Most Recent Quarter 0.79
Total Cash Per Share 6.29
Book Value Per Share Most Recent Quarter 6.83
Price to Book Ratio 6.37
Industry Price to Book Ratio 9.44
Sector Price to Book Ratio 18.99
Price to Sales Ratio Twelve Trailing Months 0.62
Industry Price to Sales Ratio Twelve Trailing Months 4.48
Sector Price to Sales Ratio Twelve Trailing Months 8.52
Analyst Buy Ratings 4
Analyst Strong Buy Ratings 1

Share Statistics
Total Shares Outstanding 3,357,979,000
Market Capitalization 149,060,687,810
Institutional Ownership N/A

Dividends
Ex-Dividend Date 3/30/2026
Previous Dividend Amount 0.5843
Current Dividend Amount 1.2174
Total Years Dividend Increasing 6
Trailing Annual Dividend Rate 1.80
Trailing Annual Dividend Yield 4.06%
Forward Annual Dividend Rate 2.43
Forward Annual Dividend Yield 5.48%
5-Year Dividend Payments Count 10
3-Year Average Dividend Yield 3.51%
5-Year Average Dividend Yield 1.91%
1-Year Dividend Growth Rate Percentage 40.99%
3-Year Dividend Growth Rate Percentage 18.74%
5-Year Dividend Growth Rate Percentage 32.08%
All-Time Dividend Growth Rate Percentage 10.45%
Dividend Payout Ratio 41.90%

Income Statement
Quarterly Earnings Growth YOY 67.10%
Annual Earnings Growth 1.43%
Reported EPS 12 Trailing Months 4.30
Reported EPS Past Year 6.63
Reported EPS Prior Year 23.03
Net Income Twelve Trailing Months 121,957,000,000
Net Income Past Year 102,434,000,000
Net Income Prior Year 100,988,000,000
Quarterly Revenue Growth YOY 24.00%
5-Year Revenue Growth 19.48%
Operating Margin Twelve Trailing Months 61.60%

Balance Sheet
Total Cash Most Recent Quarter 21,127,000,000
Total Cash Past Year 26,464,000,000
Total Cash Prior Year 15,655,000,000
Net Cash Position Most Recent Quarter -98,045,000,000
Net Cash Position Past Year -92,477,000,000
Long Term Debt Past Year 118,941,000,000
Long Term Debt Prior Year 84,246,000,000
Total Debt Most Recent Quarter 119,172,000,000
Equity to Debt Ratio Past Year 0.62
Equity to Debt Ratio Most Recent Quarter 0.63
Total Stockholder Equity Past Year 194,047,000,000
Total Stockholder Equity Prior Year 143,486,000,000
Total Stockholder Equity Most Recent Quarter 203,065,000,000

Free Cash Flow
Free Cash Flow Twelve Trailing Months 31,029,000,000
Free Cash Flow Per Share Twelve Trailing Months 9.24
Free Cash Flow Past Year 28,989,000,000
Free Cash Flow Prior Year 69,659,000,000

Options
Put/Call Ratio 0.58
Has Options Options Chain
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD 1.33
MACD Signal 1.66
20-Day Bollinger Lower Band 28.23
20-Day Bollinger Middle Band 44.51
20-Day Bollinger Upper Band 60.79
Beta 0.35
RSI 54.66
50-Day SMA 50.87
150-Day SMA 82.60
200-Day SMA 77.42

System
Modified 5/23/2026 4:30:20 AM EST